This day-long roundtable will bring together 30-40 delegates from the private sector, government, and biomedical research ecosystem in the US and China to identify opportunities that harness the power of the public, private, and non-profit sectors to ensure better outcomes for patients with breast, cervical, and ovarian cancer in both regions. Further, the roundtable will discuss the importance of bilateral cooperation in curing women’s cancers and drawing a blueprint for future work. This initiative will explore other cancers of high prevalence in both countries as part of the development of the blueprint.